NCT07438093 2026-02-27Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid TumorsThe First Affiliated Hospital of Xiamen UniversityPhase NA Not yet recruiting60 enrolled